儿童Bethesda III类甲状腺结节按核异型性亚分类的恶性风险
本研究回顾性分析2012年1月至2023年7月单中心58例儿童(<21岁)62个AUS甲状腺结节,按2023 TBSRTC分为AUS-N和AUS-O亚类并比较术后恶性率。结果显示AUS-N恶性率52%,显著高于AUS-O的15%(p=.002),提示亚分类有助于儿童AUS结节的风险分层与临床管理。
要点
- 儿童AUS甲状腺结节中,AUS-N亚类恶性率显著高于AUS-O亚类。
- AUS-N恶性率52%,AUS-O恶性率15%,差异有统计学意义(p=.002)。
- 亚分类可能指导儿童AUS结节的临床分诊与手术决策。
核心结论
- 儿童AUS甲状腺结节中,AUS-N的恶性风险显著高于AUS-O。
研究设计与样本
- 单中心回顾性研究,检索2012年1月至2023年7月病理数据库,纳入<21岁、细胞学为AUS且后续手术的甲状腺结节。
- 共纳入58例患儿62个结节,分为AUS-N 29个和AUS-O 33个,收集术后组织学结果并比较恶性率。
主要发现
- AUS-N组发现15例癌,包括11例经典型甲状腺乳头状癌(PTC)和4例滤泡型PTC。
- AUS-O组发现5例癌,包括2例PTC和3例嗜酸细胞性甲状腺癌。
- AUS-N恶性率为52%,AUS-O为15%,差异有统计学意义(p=.002)。
- 两组均以女性为主,结节大小分布相似。
关键数值与推荐
- AUS-N恶性率52%(15/29),AUS-O恶性率15%(5/33),p=.002。
临床怎么用
- 对儿童AUS甲状腺结节可进一步行AUS-N与AUS-O亚分类,以辅助风险分层和临床分诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 2023 Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) divides AUS diagnoses into two major subcategories: atypia of undetermined significance (AUS) nuclear atypia (AUS-N) and other (AUS-O). This study aims to compare the histological outcome and malignant rate of pediatric AUS thyroid nodules classified into AUS-N and AUS-O subcategories. DESIGN: A search of our institutional electronic pathology database for the period from January 2012 to July 2023 was conducted to identify pediatric (<21 years old) thyroid nodules that were interpreted as AUS and subsequently had surgery. Cases were further divided into AUS-N and AUS-O subcategories. Results of follow-up surgical resections were collected. The malignant rate was calculated and compared between AUS-N and AUS-O groups. RESULTS: The study identified 62 thyroid nodules from 58 pediatric patients. Among these nodules, 29 and 33 were subcategorized as AUS-N and AUS-O, respectively. Both groups exhibited a female predominance and displayed a similar nodule size distribution. Histological analysis revealed 15 carcinomas in AUS-N nodules, including 11 cases of classic papillary thyroid carcinoma (PTC) and four cases of follicular type of PTC. In contrast, in the AUS-O group, a total of five carcinomas were documented, including two PTCs and three oncocytic thyroid carcinomas. Notably, the malignant rate of AUS-N nodules (52%) is significantly higher than that of AUS-O nodules (15%) (p = .002). CONCLUSION: In pediatric AUS thyroid nodules, the malignant risk in AUS-N is significantly higher than that in AUS-O. These findings may guide more appropriate clinical triage and/or improve management of pediatric patients with AUS thyroid nodules.
引用
- Jin X, Jing X, Smola B, et al. Malignant risk of pediatric Bethesda category III thyroid nodules subcategorized by nuclear atypia and other: A single institution experience. Cancer Cytopathol. 2024. PMID: 38771850. doi:10.1002/cncy.22831
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。